GO:0006281 DNA repair: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006281 DNA repair is the biological process that restores DNA after damage caused by environmental agents, endogenous metabolism, or replication errors.
• Multiple repair pathways exist, including direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair, and mismatch repair.
• Defects in DNA repair drive cancer predisposition, neurodegeneration, and accelerated aging, making repair genes key therapeutic targets.
• Transcription-coupled nucleotide excision repair preferentially removes UV-induced lesions from actively transcribed genes.
• The SNM1A nuclease exemplifies specialized repair factors that process interstrand crosslinks and other complex lesions.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of DNA repair gene function in disease contexts.
Description
DNA repair (GO:0006281) is the collection of cellular pathways that detect and correct damage to the DNA molecule, thereby preserving genomic integrity. Genomes are constantly challenged by exogenous agents such as ultraviolet (UV) and ionizing radiation, chemical mutagens, and fungal or bacterial toxins, as well as by endogenous free radicals and alkylating agents generated during normal metabolism. DNA is also damaged by errors that occur during replication. Without efficient repair, mutations accumulate and can lead to cancer, neurodegeneration, and premature aging. Researchers study DNA repair to understand how cells maintain genome stability, how repair defects contribute to disease, and how these pathways can be targeted therapeutically. The process encompasses several mechanistically distinct pathways, including direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair, and mismatch repair. Each pathway relies on specialized enzymes and accessory factors that recognize specific types of lesions and restore the original DNA sequence.
DNA repair At A Glance
| GO ID | GO:0006281 |
|---|---|
| GO term | DNA repair |
| Ontology | biological_process |
| Synonym | None |
| Major function | Restoration of DNA after damage through multiple specialized pathways |
| Pathways included | Direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair, mismatch repair |
| Damage sources | UV, ionizing radiation, chemical mutagens, fungal/bacterial toxins, free radicals, alkylating agents, replication errors |
| Disease relevance | Cancer predisposition, neurodegeneration, aging, chemotherapeutic resistance |
What Is GO:0006281?
GO:0006281 DNA repair is defined as the process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g., UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
Why Is DNA repair Important in Cell Biology?
DNA repair is essential for maintaining genomic integrity and preventing the accumulation of mutations that drive cancer and other diseases. Defects in repair pathways cause hereditary cancer syndromes and neurodegenerative disorders, while upregulation of repair can confer resistance to DNA-damaging chemotherapy and radiotherapy. Understanding the molecular mechanisms of repair informs the development of targeted therapies, including PARP inhibitors and immune checkpoint combinations. Moreover, repair pathways are critical for the efficacy of gene editing technologies such as CRISPR, because cells must repair the programmed double-strand breaks to achieve desired edits.
• Prevents mutations that lead to cancer and hereditary disease.
• Maintains genome stability during replication and transcription.
• Enables cellular survival after exposure to UV, radiation, and chemical mutagens.
• Defects cause neurodegenerative disorders and accelerated aging.
• Repair capacity influences chemotherapy and radiotherapy response.
• Transcription-coupled repair protects actively transcribed genes from UV damage.
• Specialized nucleases like SNM1A resolve complex DNA crosslinks.
• Chromothripsis can result from combined repair and checkpoint defects.
• Repair pathways determine CRISPR editing outcomes and precision.
• Targeting repair vulnerabilities offers therapeutic opportunities in cancer.
What Happens During DNA repair?
Damage recognition and signaling
In simple terms: The cell first senses that DNA is broken or altered and sends alarm signals.
DNA damage is detected by sensor proteins that recognize structural distortions, single-strand breaks, or double-strand breaks. This triggers checkpoint signaling that arrests the cell cycle and recruits repair factors to the lesion site. The DNA damage response coordinates repair with cell cycle progression to ensure that damage is fixed before replication or mitosis.
Direct reversal and base excision repair
In simple terms: Some damage can be simply reversed, while small base lesions are cut out and replaced.
Direct reversal enzymes remove certain alkyl or photoproduct lesions without excising the base. Base excision repair (BER) removes damaged or incorrect bases through glycosylases, followed by AP endonuclease cleavage, DNA polymerase filling, and ligation. BER is the primary pathway for repairing oxidative and alkylation damage.
Nucleotide excision repair and transcription-coupled repair
In simple terms: Bulky damage is cut out as a short patch and the gap is filled using the opposite strand as a template.
Nucleotide excision repair (NER) removes bulky adducts and UV-induced photoproducts by dual incision flanking the lesion, excision of an oligonucleotide, and resynthesis. Transcription-coupled NER specifically targets lesions that block RNA polymerase II, ensuring rapid repair of actively transcribed genes.
Double-strand break repair
In simple terms: Breaks in both DNA strands are fixed either by precise copying from a sister template or by joining broken ends.
Double-strand breaks are repaired primarily by homologous recombination (HR) or non-homologous end joining (NHEJ). HR uses a homologous template for high-fidelity repair, while NHEJ ligates ends directly and can be error-prone. Defects in these pathways cause chromosomal instability and are linked to cancer and chromothripsis.
Mismatch repair and bypass
In simple terms: Replication errors are corrected, and some lesions are tolerated by specialized polymerases.
Mismatch repair (MMR) corrects base mismatches and insertion-deletion loops that escape proofreading during replication. Translesion synthesis (bypass) allows replication to proceed past unrepaired lesions using specialized polymerases, albeit with a risk of mutagenesis.
Key Genes Involved in GO:0006281 DNA repair
The following genes encode core components of DNA repair pathways and are frequently studied in cancer, neurodegeneration, and genome editing research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Checkpoint activation and apoptosis after DNA damage | Most mutated gene in cancer; models for therapy response |
| BRCA1 | Homologous recombination and double-strand break repair | Hereditary breast/ovarian cancer; PARP inhibitor sensitivity |
| BRCA2 | Homologous recombination, RAD51 loading | Fanconi anemia and breast cancer predisposition |
| ATM | DNA damage checkpoint kinase | Ataxia-telangiectasia; radiosensitivity |
| ATR | Replication stress checkpoint kinase | Chemotherapy sensitivity; synthetic lethality |
| XRCC1 | Base excision repair scaffold | BER efficiency; chemoresistance |
| ERCC1 | Nucleotide excision repair endonuclease complex | NER deficiency; cisplatin response |
| XPA | Damage recognition in NER | Xeroderma pigmentosum; UV sensitivity |
| MLH1 | Mismatch repair | Lynch syndrome; microsatellite instability |
| MSH2 | Mismatch repair | Lynch syndrome; immunotherapy response |
| RAD51 | Homologous recombination strand invasion | HR proficiency; PARP inhibitor resistance |
| SNM1A | Interstrand crosslink processing nuclease | Crosslink repair; chemosensitivity |
| POLQ | Theta-mediated end joining | Alternative DSB repair; CRISPR editing outcomes |
| LIG4 | Non-homologous end joining ligation | NHEJ deficiency; radiosensitivity |
| FANCD2 | Fanconi anemia pathway | Crosslink repair; bone marrow failure |
| CHEK2 | Checkpoint kinase | Hereditary cancer risk |
| PARP1 | Poly(ADP-ribose) polymerase; BER and SSB repair | PARP inhibitor target; synthetic lethality |
How Is DNA repair Regulated?
DNA repair is regulated at multiple levels, including cell cycle-dependent expression, post-translational modifications (phosphorylation, ubiquitination, SUMOylation), and chromatin remodeling. Checkpoint kinases ATM and ATR coordinate repair with cell cycle arrest, and their activity is modulated by replication stress and DNA damage load. Transcription-coupled repair is coupled to RNA polymerase II elongation and is regulated by factors that sense transcription-blocking lesions. Additionally, repair pathway choice between HR and NHEJ is influenced by cell cycle phase and cyclin-dependent kinase activity.
DNA repair and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Hereditary breast and ovarian cancer; HR deficiency | Knockout in breast epithelial cells; PARP inhibitor sensitivity assay |
| MLH1 | Lynch syndrome; microsatellite instability | Knockout in colorectal cancer cell lines; MMR functional assay |
| ATM | Ataxia-telangiectasia; radiosensitivity | Point-mutation knock-in in neuronal cells; radiation survival |
| XPA | Xeroderma pigmentosum; UV sensitivity | Knockout in fibroblasts; UV survival and NER assay |
| SNM1A | Crosslink repair deficiency; chemosensitivity | Knockout in cancer cells; cisplatin sensitivity |
Cancer and DNA repair defects
Defects in DNA repair pathways are hallmarks of many cancers. BRCA1/2 mutations impair homologous recombination and predispose to breast and ovarian cancer, while mismatch repair deficiency causes Lynch syndrome and microsatellite instability. Tumors with repair defects can be targeted by synthetic lethality, such as PARP inhibitors in HR-deficient cancers.
Neurodegeneration and aging
Post-mitotic neurons are highly dependent on DNA repair, and defects in repair contribute to neurodegenerative diseases and brain injury outcomes. Accumulation of DNA damage is a feature of aging and age-related neurodegeneration, linking repair capacity to neuronal survival.
Chromothripsis and genomic catastrophe
Combined defects in DNA repair and checkpoint control can lead to chromothripsis, a phenomenon of massive chromosomal rearrangements in a single event. This has been observed in cancer and congenital disorders, highlighting the importance of coordinated repair and checkpoint functions.
From DNA repair-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BRCA1 impair homologous recombination? | BRCA1 knockout cell line; RAD51 foci assay |
| Does a specific ATM mutation affect checkpoint signaling? | ATM point-mutation knock-in; phospho-CHK2 Western blot |
| Can overexpression of RAD51 rescue HR deficiency? | RAD51 overexpression in BRCA1-mutant cells; survival assay |
| How does SNM1A contribute to crosslink repair? | SNM1A knockout; comet assay and cisplatin sensitivity |
| What is the role of TP53 in DNA damage response? | TP53 knockout; apoptosis and cell cycle analysis |
| Does MLH1 deficiency cause microsatellite instability? | MLH1 knockout; MSI PCR panel |
How to Study the DNA repair Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Comet assay | DNA strand breaks | Quantifying damage and repair kinetics |
| gamma-H2AX foci | Double-strand breaks | Assessing DSB repair capacity |
| RAD51 foci | Homologous recombination activity | HR proficiency in cancer cells |
| RNA-seq | Transcriptional response to damage | Identifying repair gene expression signatures |
| Whole-genome sequencing | Mutations and structural variants | Detecting repair defects and mutational signatures |
| Mass spectrometry | Protein interactions and modifications | Mapping repair complexes |
| Live-cell imaging | Real-time protein recruitment | Visualizing repair foci dynamics |
Genomic and transcriptomic profiling
RNA-seq and whole-genome sequencing can identify mutations in repair genes and measure transcriptional responses to DNA damage, such as UV-induced gene expression changes. These methods help classify repair deficiencies and predict therapeutic vulnerabilities.
Functional repair assays
Comet assay, gamma-H2AX foci staining, and RAD51 foci formation are used to measure DNA damage and repair capacity in cells. These assays are essential for validating CRISPR models and assessing drug sensitivity.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify repair complex components and post-translational modifications after damage. Proximity labeling and immunoprecipitation reveal dynamic interactions during repair.
Imaging and live-cell analysis
Fluorescence microscopy of GFP-tagged repair proteins allows real-time visualization of repair foci and recruitment kinetics. This approach is valuable for studying spatial and temporal regulation of repair.
How CRISPR Can Be Used to Study GO:0006281 DNA repair
Knockout
CRISPR knockout of DNA repair genes is used to create isogenic models of repair deficiency, enabling studies of synthetic lethality and drug sensitivity. For example, BRCA1 or MLH1 knockout cells recapitulate key features of hereditary cancers.
Point Mutation
Point-mutation knock-in via CRISPR allows precise modeling of clinically relevant missense mutations in repair genes, such as ATM or TP53 variants, to dissect their functional impact on checkpoint and repair activities.
Knock-in
Knock-in of reporter tags or epitope tags (e.g., GFP, HA) into endogenous repair gene loci enables real-time tracking of protein localization and dynamics without overexpression artifacts.
Overexpression
CRISPR-mediated overexpression or cDNA delivery can test whether increased repair gene dosage rescues defects or confers resistance to DNA-damaging agents, as seen with RAD51 overexpression in HR-deficient cells.
How EDITGENE Supports DNA repair Research
Researchers studying DNA repair-related genes often need to determine whether a candidate gene is causally involved in repair, disease predisposition, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of DNA repair genes in relevant biological contexts.
Contact EDITGENE today to design your custom CRISPR model for DNA repair research.
Frequently Asked Questions About DNA repair
What is DNA repair (GO:0006281)?
DNA repair is the biological process that restores DNA after damage caused by environmental agents, metabolism, or replication errors, through multiple pathways such as base excision repair, nucleotide excision repair, and double-strand break repair.
What genes are involved in DNA repair?
Key genes include TP53, BRCA1, BRCA2, ATM, ATR, XRCC1, ERCC1, XPA, MLH1, MSH2, RAD51, and PARP1, among many others.
Why is DNA repair important for cancer?
Defects in DNA repair lead to mutation accumulation and cancer predisposition, while repair proficiency can cause resistance to chemotherapy and radiotherapy.
What are the main DNA repair pathways?
The main pathways are direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair, and mismatch repair.
How does transcription-coupled repair work?
Transcription-coupled nucleotide excision repair removes UV-induced lesions from actively transcribed genes by coupling repair to RNA polymerase II elongation.
What is the role of SNM1A in DNA repair?
SNM1A is a nuclease that processes interstrand crosslinks and other complex DNA lesions, contributing to crosslink repair.
Can DNA repair defects cause neurodegeneration?
Yes, defects in DNA repair contribute to neurodegenerative diseases and brain injury outcomes, as post-mitotic neurons rely heavily on repair.
What is chromothripsis and how is it related to DNA repair?
Chromothripsis is massive chromosomal rearrangement in a single event, often caused by combined defects in DNA repair and checkpoint control.
How can CRISPR be used to study DNA repair genes?
CRISPR knockout, point-mutation knock-in, and overexpression models allow functional dissection of repair genes in disease and therapy response.
What methods are used to measure DNA repair?
Common methods include comet assay, gamma-H2AX foci, RAD51 foci, RNA-seq, and whole-genome sequencing.
Conclusion
DNA repair (GO:0006281) is a fundamental biological process that safeguards genome integrity through a network of specialized pathways. Its dysfunction underlies cancer, neurodegeneration, and aging, while its modulation influences therapeutic outcomes. Continued research using advanced CRISPR models and functional assays will further illuminate repair mechanisms and translate them into clinical advances.
References
- 1. Hopkins JL et al.. 2022. DNA repair defects in cancer and therapeutic opportunities.. Genes Dev 36(5-6):278-293 PMID: 35318271
- 2. Sancar A et al.. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.. Annu Rev Biochem 73:39-85 PMID: 15189136
- 3. Nieto Moreno N et al.. 2023. Transcription-Coupled Nucleotide Excision Repair and the Transcriptional Response to UV-Induced DNA Damage.. Annu Rev Biochem 92:81-113 PMID: 37040775
- 4. Barnes DE et al.. 1993. DNA repair.. Curr Opin Cell Biol 5(3):424-33 PMID: 8352959
- 5. Davis CK et al.. 2021. DNA damage and repair following traumatic brain injury.. Neurobiol Dis 147:105143 PMID: 33127471
- 6. Simovic M et al.. 2022. Chromothripsis, DNA repair and checkpoints defects.. Semin Cell Dev Biol 123:110-114 PMID: 33589336
- 7. Alhegaili AS. 2023. Role of DNA Repair Deficiency in Cancer Development.. Pak J Biol Sci 26(1):15-22 PMID: 37129201
- 8. Baddock HT et al.. 2020. The SNM1A DNA repair nuclease.. DNA Repair (Amst) 95:102941 PMID: 32866775
